Cover Image
市場調查報告書

高粘度藥液的自我施打

Self Administration of High Viscosity Drugs

出版商 Greystone Research Associates 商品編碼 345525
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
高粘度藥液的自我施打 Self Administration of High Viscosity Drugs
出版日期: 2015年11月24日 內容資訊: 英文
簡介

本報告提供通常無法使用患者自我施打設備、技術給藥的粘度高的藥液的自我施打市場相關調查、高粘度藥液的技術與設備、設計因素、材料選擇的問題、調劑因素,及設備的功能與限制相關分析、注射劑與設備製造商簡介、市場資料與預測,及自我施打高粘度藥液的經濟、技術、規定人員的影響評估等。

摘要整理

市場機會

  • 注射劑的經濟學
  • 注射劑趨勢、推動市場的要素
  • 治療需求的促進要素
  • 競爭情形
  • 風險因素

高粘度注射設備:設計因素

  • 藥液的特徵
  • 藥液貯存的必要條件
  • 注射方法
  • 基本的設備功能
  • 主要包裝
  • 冷凍乾燥藥物/重組
  • 人因工程/人體工學
  • 調劑技術

高粘度藥液注射:設備分析

  • 特殊自動注射器
  • 塑膠注射器
  • 穿戴式皮下注射器
  • 貼片狀設備
  • 其他的設備級

高粘度藥液注射:目前市場

  • 組合產品
  • 開發階段的產品
  • 聯盟、合作

高粘度藥液注射:主要的治療部門分析

  • 治療部門
  • 市售的注射劑
  • 預測、展望

市場因素

  • 管理方案
  • 病人依從性、可用性
  • 醫療經濟學

企業簡介

目錄
Product Code: HVK429R

Devices, Therapies, Players, Strategies and Forecasts

image1

Formulations that Push the Device Envelope

Growth in biological drugs has been driven by advances in biotechnology and host-vector engineering - advances that have led to a steady stream of biologics for a number of ailments and conditions. These powerful drugs come with a high cost-per-dose and the risk of significant side effects - factors that place an elevated emphasis on administration efficiency, safety and reliability. Many drugs in this class are characterized by physical properties and sensitivities that challenge the drug commercialization ecosystem. For example, monoclonal antibodies, perhaps the most significant category in terms of therapeutic and commercial importance, typically possess viscosities that are well above the normal limits of subcutaneous injection techniques. Drug developers and device designers are increasingly working in collaboration to address the goal of patient self-administration for biological injectables.


The value we provide to our clients and subscribers is best illustrated by our ability to consistently provide strategic direction and market knowledge that contributes to their tactical and strategic decision process.

Tailored Research

As technology and products evolve, the level of precision in management decisions required to enable effective company performance is increasing. Such precision cannot be achieved without timely and accurate data about the company's macroscopic operating environment. The information that you and your management team require to execute your business and market strategies is unique to your organization and business model. This is why - in addition to the multi-client reports you will find on our site - we offer client-specific research services that start with customer-defined needs and culminate in assessments and analysis that answer the questions that represent risk to your business strategy. To discuss Greystone's Customer Defined Research services, we invite you to contact us.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

'Most biological products are stored at 2 to 8°C. To avoid injection pain, an injectable/infusible drug is typically equilibrated to room temperature prior injection. The effect of temperature on viscosity is non-negligible and has to be factored into any product development program relying on a delivery method other than a traditional infusion set.' Table of Contents

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.

What You Will Learn

  • Analyzes the market for therapeutic drugs with viscosities that cannot be delivered using standard patient self-injection devices and techniques
  • Assesses technologies and devices that are aimed at positioning high viscosity drugs for patient self-administration, including injection devices and viscosity-lowering formulation techniques
  • Analyzes design factors, material selection issues, formulation factors, and device capabilities and limitations
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Evaluates key therapeutic sectors for high viscosity injectables
  • Provides market data and forecasts to 2020
  • Evaluates the impact of economic, technology, and regulatory factors on high viscosity drugs for self administration

image2

Table of Contents

Executive Summary

The Market Opportunity

  • The Economics of Injectable Drugs
  • Injectable Drug Trends and Market Drivers
    • Prefilled Devices
    • Self-Administration
    • Shifting Demographics
    • Injector Design Innovation
  • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors

High Viscosity Injection Devices - Design Factors

  • Drug Properties (T/C/V)
  • Drug Storage Requirements
  • Injection Methodology
  • Baseline Device Capabilities
  • Primary Packaging
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics
  • Formulation Technology

High Viscosity Injection - Device Analysis

  • Specialty Autoinjectors
  • Plastic Syringes
  • Wearable Subcutaneous Infusion Devices
  • Patch-like Devices
  • Other Device Classes

High Viscosity Injectables - the Current Market

  • Combination Products
  • Development-stage Products
  • Alliances and Collaborations

High Viscosity Injectables - Key Therapeutic Sector Analysis

  • Therapy Sectors
  • Commercialized Injectables
  • Forecasts and Prospects

Market Factors

  • Regulatory Initiatives
  • Patient Compliance and Ease of Use
  • Healthcare Economics

Company Profiles

Back to Top